This is supported by cytokine analysis of the tumor microenvironment that reflected a Th1 cell-mediated immune response within the tumor with increased levels of IFN gamma, IL-12, IL-1, and IL-8 in the metastatic deposits. The gene discussed is IL1B; the disease is neoplasm.